TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22073385

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 19479079

Group type: EXPERIMENTAL
Intervention: zidovudine/lamivudine+lopinavir/ritonavir
Number of subjects: 50

Group type: COMPARATOR
Intervention: nevirapine+lopinavir/ritonavir
Number of subjects: 50
Study: 17429101

Group type: COMPARATOR
Intervention: No Gap (immediate treatment)
Number of subjects: 2215

Group type: EXPERIMENTAL
Intervention: Gap (16-week delay)
Number of subjects: 2215
Study: 15552889

Group type: EXPERIMENTAL
Intervention: Protease inhibitors, H2 receptor antagonists, and somatostatin analogues
Number of subjects: 0
Study: 11380290

Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 51
Study: 9171743

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy trials
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair trials
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy trials
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall trials reviewed
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Economic aspects study
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sample size calculation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Endpoints assessment
Number of subjects: 40
Study: 8483655

Group type: EXPERIMENTAL
Intervention: Group 1 - 'Big Band' music from the 1920s and 1930s during daily recreation period
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group 2 - Puzzle exercises during activity sessions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group 3 - Standard recreational activities of drawing and painting
Number of subjects: 60
Study: 3301220

Group type: EXPERIMENTAL
Intervention: Sulfur 2 percent plus salicylic acid 2 percent in a shampoo vehicle
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sulfur 2 percent in a shampoo vehicle
Number of subjects: 48

Group type: COMPARATOR
Intervention: Salicylic acid 2 percent in a shampoo vehicle
Number of subjects: 48

Group type: COMPARATOR
Intervention: Shampoo vehicle alone
Number of subjects: 48
Study: 30009974

Group type: EXPERIMENTAL
Intervention: Radial subluxation ratio
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Grip strength scores
Number of subjects: 100
Study: 26563167

Group type: EXPERIMENTAL
Intervention: Mesalamine granules (MG) 1.5 g once daily
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 24802242

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir (ATV/r) alone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (2 NRTI plus protease inhibitor)
Number of subjects: 34
Study: 22285578

Group type: EXPERIMENTAL
Intervention: CRT with lateral LV lead position
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: CRT with non-apical LV lead position
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: CRT with lateral LV position
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: CRT with non-apical LV position
Number of subjects: 346

Group type: COMPARATOR
Intervention: RV apical lead position
Number of subjects: 346
Study: 20348362

Group type: EXPERIMENTAL
Intervention: Implicit Relational Assessment Procedure (IRAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit attitudes towards overweight individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IRAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicit measure
Number of subjects: 0
Study: 18595176

Group type: EXPERIMENTAL
Intervention: Guided peer support group (GPSG)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 106
Study: 15772960

Group type: EXPERIMENTAL
Intervention: Randomized studies
Number of subjects: 17
Study: 12523214

Group type: EXPERIMENTAL
Intervention: Improved hand hygiene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Available space per child
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noise and indoor climate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time spent outdoors
Number of subjects: 0
Study: 10632035

Group type: COMPARATOR
Intervention: Normal individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spinal cord-injured patients
Number of subjects: 0
Study: 7488477

Group type: EXPERIMENTAL
Intervention: Paravertebral block with bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Interpleural block with bupivacaine
Number of subjects: 45
Study: 1592850

Group type: EXPERIMENTAL
Intervention: Pretransfusion radiofrequency heating of stored blood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unwarmed blood pack
Number of subjects: 0
Study: 6092990

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (45‐60 mg/M2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31498137

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT) - less affected limb blocked by a splint
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group - undergoing bi-manual treatment
Number of subjects: 10
Study: 30045424

Group type: EXPERIMENTAL
Intervention: 1% energy trans fatty acid supplementation
Number of subjects: 53

Group type: COMPARATOR
Intervention: <0.01% energy trans fatty acids (control)
Number of subjects: 53
Study: 24228803

Group type: EXPERIMENTAL
Intervention: DHA (500mg daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DHA plus EPA mixture (500mg daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wheat germ oil (control)
Number of subjects: 36
Study: 21950727

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 19174534

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 17197000

Group type: EXPERIMENTAL
Intervention: Aware of bedtime
Number of subjects: 14

Group type: COMPARATOR
Intervention: No knowledge of bedtime
Number of subjects: 14

Group type: COMPARATOR
Intervention: Misinformed about bedtime
Number of subjects: 14
Study: 16080791

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum ME‐3 in fermented goat milk (daily dose 11.8 log CFU)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum ME‐3 in capsules (daily dose 9.2 CFU)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 45

Group type: COMPARATOR
Intervention: Goat milk (control for fermented milk)
Number of subjects: 45
Study: 12154153

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment (up to 40 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium treatment (up to 1,200 mg/day)
Number of subjects: 0
Study: 9479069

Group type: EXPERIMENTAL
Intervention: Semantic word classes (6 classes based on factor analysis of word ratings)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Checkerboard reversal stimulus (control condition)
Number of subjects: 52
Study: 7995059

Group type: EXPERIMENTAL
Intervention: Single pulse therapy (500 mg of methylprednisolone)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Second pulse therapy at 24 hours (500 mg of methylprednisolone)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Second pulse therapy at 48 hours (500 mg of methylprednisolone)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Second pulse therapy (at 24h and 48h)
Number of subjects: 90
Study: 2838681

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMW heparin)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard unfractionated heparin (UF heparin)
Number of subjects: 70
Study: 30982972

Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver
Number of subjects: 108
Study: 29606103

Group type: EXPERIMENTAL
Intervention: Combined educational and environmental intervention in the workplace
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (one organization)
Number of subjects: 145
Study: 28643094

Group type: EXPERIMENTAL
Intervention: Double reading of tomosynthesis + S‐2D (F)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Single reading of S‐2D alone (A)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Single reading of tomosynthesis alone (B)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Single reading of joint interpretation of tomosynthesis + S‐2D (C)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Double reading of S‐2D alone (D)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Double reading of tomosynthesis alone (E)
Number of subjects: 163
Study: 25837379

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 267
Study: 23912139

Group type: EXPERIMENTAL
Intervention: Start For Life intervention (30 minutes/day for 9 months)
Number of subjects: 0
Study: 21429793

Group type: EXPERIMENTAL
Intervention: Preventive programme in addition to usual care
Number of subjects: 522

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 522
Study: 19129044

Group type: EXPERIMENTAL
Intervention: Proposed estimation method using the expectation maximization (EM) algorithm with the bootstrap method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed testing procedure
Number of subjects: 0
Study: 16337497

Group type: EXPERIMENTAL
Intervention: Nicorandil (2 mug/kg/min, intravenously for 6 hours)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 192
Study: 14605030

Group type: EXPERIMENTAL
Intervention: Abrupt discontinuation of nitrate treatment (study group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continuation of nitrate treatment (control group)
Number of subjects: 120
Study: 11117089

Group type: EXPERIMENTAL
Intervention: Notch depth index (NDI) with a cutoff value of 0.14
Number of subjects: 288

Group type: COMPARATOR
Intervention: Uterine artery resistance index (RI)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Peak systolic to early diastolic velocity (A/C) ratio
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: NDI with a cutoff value of 0.14
Number of subjects: 288
Study: 8975965

Group type: EXPERIMENTAL
Intervention: 5 MU IFN daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 MU IFN plus regular phlebotomies
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3 MU IFN administered 3 x week for 6 months (control)
Number of subjects: 30
Study: 1401602

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 613

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study: 3890700

Group type: EXPERIMENTAL
Intervention: Mesulergine 10 mg daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mesulergine 20 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Levodopa-carbidopa (LD-CD)
Number of subjects: 20
Study: 31389383

Group type: EXPERIMENTAL
Intervention: Imatinib + ara-c
Number of subjects: 30

Group type: COMPARATOR
Intervention: Imatinib alone
Number of subjects: 30
Study: 30007996

Group type: EXPERIMENTAL
Intervention: Sensorimotor integration training combined with conventional physiotherapy, 2 times per week for 6 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 24
Study: 27003201

Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Distance (6MWD)
Number of subjects: 187
Study: 24189151

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infants of mothers on ART
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infants of mothers with CD4 counts ≥ 350 cells/mm³ not on ART
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NVP and Placebo
Number of subjects: 0
Study: 22507901

Group type: EXPERIMENTAL
Intervention: HACE
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: HAE
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both HACE and HAE
Number of subjects: 26
Study: 20454927

Group type: EXPERIMENTAL
Intervention: Ixabepilone plus capecitabine (40 mg/m² intravenously on day 1 of a 21-day cycle plus 2,000 mg/m² orally on days 1-14 of a 21-day cycle)
Number of subjects: 752

Group type: COMPARATOR
Intervention: Capecitabine alone (2,500 mg/m² on the same schedule)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Ixabepilone plus capecitabine in KPS 70-80 subgroup
Number of subjects: 752
Study: 17989373

Group type: EXPERIMENTAL
Intervention: Aspirin (median dosage per week: 1300 mg)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Clopidogrel (median dosage per week: 525 mg)
Number of subjects: 76
Study: 15900423

Group type: EXPERIMENTAL
Intervention: External-beam irradiation administered as a 60-Gy dose under conditions of acute hypoxia
Number of subjects: 307

Group type: COMPARATOR
Intervention: External-beam irradiation administered as a 40-Gy dose under normal oxygenation conditions
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Extended-field irradiation up to T12 in hypoxic condition
Number of subjects: 307

Group type: COMPARATOR
Intervention: Extended-field irradiation up to L4 in hypoxic condition
Number of subjects: 307

Group type: COMPARATOR
Intervention: Lower dose under normoxic conditions
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Hypoxyradiotherapy
Number of subjects: 307
Study: 12107951

Group type: EXPERIMENTAL
Intervention: Two health screenings
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Two health screenings and a 45-minute follow-up consultation annually with their general practitioner
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group (no health screenings)
Number of subjects: 2000
Study: 10063243

Group type: EXPERIMENTAL
Intervention: Child Drawing: Hospital
Number of subjects: 0
Study: 7590643

Group type: EXPERIMENTAL
Intervention: 150 micrograms 3-keto-desogestrel (KDG) with 30 micrograms ethinylestradiol (EE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 micrograms desogestrel (DG) with 30 micrograms ethinylestradiol (EE)
Number of subjects: 0
Study: 2249126

Group type: EXPERIMENTAL
Intervention: Desmopressin 20 micrograms
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Desmopressin 40 micrograms
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 537624

Group type: EXPERIMENTAL
Intervention: Atypia in colorectal adenomatous polyps
Number of subjects: 3
Study: 31467066

Group type: EXPERIMENTAL
Intervention: Long-acting G-CSF for all chemotherapy cycles
Number of subjects: 84

Group type: COMPARATOR
Intervention: Short-acting G-CSF for first cycle and treatment per physician discretion for subsequent cycles
Number of subjects: 84
Study: 27932353

Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg/d) + Statin (E+S)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Statin Monotherapy (S)
Number of subjects: 260
Study: 26692013

Group type: EXPERIMENTAL
Intervention: Circulating 25-hydroxyvitamin D concentration
Number of subjects: 5545
Study: 23606983

Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg at bed time)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (100 ug twice daily)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Both montelukast and fluticasone
Number of subjects: 203
Study: 21385145

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily after THR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rivaroxaban after TKR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabigatran 220 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dabigatran
Number of subjects: 0
Study: 19923527

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg IV before incision, 24-h infusion at 2 microg x kg(‐1) x min(‐1))
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo (blinded saline bolus and infusion)
Number of subjects: 154
Study: 17352522

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clopidogrel added to aspirin therapy
Number of subjects: 0
Study: 15539040

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (at least 45 min, 5 days/week for 12 months)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 173
Study: 11418225

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg per day
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 9251877

Group type: EXPERIMENTAL
Intervention: Individualized homoeopathic prophylaxis
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 8389421

Group type: EXPERIMENTAL
Intervention: Soluble fiber diet
Number of subjects: 43

Group type: COMPARATOR
Intervention: Insoluble fiber diet
Number of subjects: 43
Study: 3120604

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31904418

Group type: EXPERIMENTAL
Intervention: RT-RPA assay
Number of subjects: 238

Group type: COMPARATOR
Intervention: Simplex RT-PCR
Number of subjects: 238

Group type: COMPARATOR
Intervention: Multiplex RT-PCR
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: RT-RPA, Simplex RT-PCR, Multiplex RT-PCR, ELISA
Number of subjects: 238
Study: 29865941

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis with plantar flexion stop
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis with plantar flexion resistance
Number of subjects: 42

Group type: COMPARATOR
Intervention: Shod gait without an ankle-foot orthosis
Number of subjects: 42
Study: 26968750

Group type: EXPERIMENTAL
Intervention: Translated letter
Number of subjects: 60
Study: 24887239

Group type: EXPERIMENTAL
Intervention: Nasal saline irrigation (NSI)
Number of subjects: 860
Study: 22687704

Group type: EXPERIMENTAL
Intervention: Group A - Posted questionnaires with both electronic and paper response options for both the initial and reminder postal requests
Number of subjects: 752

Group type: COMPARATOR
Intervention: Group B - Posted questionnaires with an electronic response option for the initial request, and both electronic and paper response options for the reminder postal request
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 752

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 752
Study: 20232761

Group type: EXPERIMENTAL
Intervention: Continuous low intensity training programme (8 weeks, 35‐9% HR max reserve, 45-60 minutes)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Continuous low intensity training programme
Number of subjects: 217
Study: 18361309

Group type: EXPERIMENTAL
Intervention: Prophylaxis intervention for tuberculosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylaxis intervention for leprosy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group for tuberculosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group for leprosy
Number of subjects: 0
Study: 15940774

Group type: COMPARATOR
Intervention: Acetaminophen 4000 mg
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Celecoxib 200 mg
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Rofecoxib 12.5 mg
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Rofecoxib 25 mg vs Celecoxib 200 mg
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Pooled analysis of VACT1/VACT2
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 1578
Study: 12408199

Group type: EXPERIMENTAL
Intervention: Intervention strategy implementing school environmental change with adult leader and youth participation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study: 11563412

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg with sertraline 50 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Zolpidem alone
Number of subjects: 28
Study: 7735741

Group type: EXPERIMENTAL
Intervention: Low-residue diet
Number of subjects: 281

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 281
Study: 1782951

Group type: EXPERIMENTAL
Intervention: alteplase 100 mg in 3 h
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study: 7048992

Group type: COMPARATOR
Intervention: PEEP = 0 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PEEP = 5 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PEEP = 10 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PEEP = 20 cm H2O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intrapulmonary nonshunt flow (Qt‐Qs)
Number of subjects: 12
Study: 31470829

Group type: EXPERIMENTAL
Intervention: Active Plus intervention group
Number of subjects: 540

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 540
Study: 27893045

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (thiazide-type diuretic)
Number of subjects: 22180

Group type: EXPERIMENTAL
Intervention: Chlorthalidone vs Lisinopril
Number of subjects: 22180

Group type: EXPERIMENTAL
Intervention: Chlorthalidone vs Amlodipine
Number of subjects: 22180

Group type: EXPERIMENTAL
Intervention: Chlorthalidone vs Lisinopril or Amlodipine (entire trial and posttrial follow-up)
Number of subjects: 22180
Study: 25087908

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (18 or 24 International Units), administered twice-daily for 8 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo nasal spray, administered twice-daily for 8 weeks
Number of subjects: 50
Study: 24910215

Group type: EXPERIMENTAL
Intervention: Intramedullary fixation using the Sonoma Wrx device
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard volar locking plate fixation
Number of subjects: 64
Study: 22504044

Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment
Number of subjects: 1189
Study: 19265481

Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine (PCV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects (first dose of vaccine)
Number of subjects: 0
Study: 17506956

Group type: EXPERIMENTAL
Intervention: Educational/informative intervention (booklet of information about prophylactic aspects and care of atopic dermatitis)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: Control group (current clinical practice)
Number of subjects: 1247